Skip to main content
Subscribe
  • Login
  • My Account
  • Logout
  • Register For Free
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HLTH 2024
    • Sponsored Content: Vital Signs Blog
  • Opinion
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Healthcare Marketing Impact Awards
    • Innovators Awards
    • Diversity Leaders
    • Leading Women
    • Best in Business Awards
    • The 2030 Playbook Conference
    • Innovations in Patient Experience
    • Leading Women Conference & Awards Luncheon
    • Leadership Summit
    • Workforce Summit
    • Best Places to Work Awards Gala
    • Diversity Leaders Gala
    • - Looking Ahead to 2025
    • - Financial Growth
    • - Hospital of the Future
    • - Value Based Care
    • - Looking Ahead to 2026
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Skilled Nursing Facilities
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
    • Sponsored Content
MENU
Breadcrumb
  1. Home
  2. Politics & Policy
August 07, 2023 04:00 AM

Q&A with Kim Keck, Blue Cross Blue Shield Association CEO

Nona Tepper
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Kim Keck

    Congress left behind a lot of unfinished business when it departed Washington last week to commence a month-long recess, including matters of vital importance to the health insurance sector. Modern Healthcare spoke with Blue Cross Blue Shield Association CEO Kim Keck about the federation's policy agenda for the remainder of 2023.

    The Blue Cross Blue Shield Association–which comprises 34 licensees that insure one-third of Americans—unveiled a suite of policy proposals aimed at making healthcare more affordable, for example, by taking aim at providers and drugmakers. Keck outlined several issues that Blues' plans hope Congress addresses as the end of the fiscal year approaches on Sept. 30. This interview has been edited for length and clarity.

    On costs and provider consolidation

    The prices of healthcare services are what drive the cost of health insurance, and those prices are largely hospitals and drugs. So one of the components is about increasing competition in the provider space.

    We've seen tremendous consolidation in the provider space. We know what happens when that consolidation happens. Providers merge with providers, often hospital systems buy physician groups, and our data would suggest costs go up.

    Another component is all the things that increase access to affordable drugs. We're doing that from a policy perspective, but also from how we're investing our dollars.

    The third component of the affordability platform is largely around what we call person-centered care or quality care. This whole notion of removing ourselves from our fee-for-service system in the United States, where somebody else's revenue was really our cost, and really moving to a place where we're outcomes-based, and we're coordinated, and we’re team-based, and we're using technology and we're more incenting efficient care.

    On site-neutral payments

    One of the biggest pieces of our platform is site-neutral payments. It's getting a ton of traction on the Hill, and we'll see where it lands. The fact that we've had as much conversation both in the House and the Senate on this topic is not inconsequential. We know from our own data that you can get a mammogram at your physician's office versus a hospital outpatient facility, and that might be the same exact image, and the price can be 20%-25% higher in one place than it is in the other. In some instances, chemotherapies can be 2-3 times higher, depending on the setting. Lots of other image-related services would fall in that category.

    That would probably be an example of the biggest component of a policy change that could get at the impacts from the consolidation that's already happened, and could at least level the playing field to say we can't necessarily ask people to pay more for the same service just because it's in a different place.

    It has tremendous pushback from the hospital association. But, candidly, it’s getting a lot of traction on the Hill as an issue that just makes sense to the average person.

    On Center for Medicare and Medicaid Innovation initiatives

    We've also been working on advancing some of the models in [the CMMI] to say, look, we've tried some of these models and value-based care for the better part of a decade, we need to institutionalize them. They have to just be part of how we practice across payers and providers.

    I think there's been a lot of good work. My gut here is that we need to focus. [Innovation center Director Liz Fowler] and her team have done a lot to take out programs that might not have been producing outcomes at the pace or at the impact that that we were all expecting. I happen to believe we should not just experiment—we should make permanent.

    I don't want to call them mandatory, but I want to force us to say we've got to stop making these incremental incentive payments for quality and innovation, candidly, and make them just the way we expect care to be delivered and reimbursed.

    On PBMs and drug prices

    I don't think there's one model that works best within the PBM space. Having said that, we've got to get our list prices on drugs to be lower. The reality is we know that so many of our medications are out of reach because they just cost so much.

    The data we have from PBMs would say that, in many instances, there's reductions in cost upwards of 50% of what those list prices are today because of the fact that the PBM exists. I think that we have innovated around this space [but] I don't think the pace of change has been happening where we really need it.

    Transparency and PBMs seem to be a big theme across the Senate Finance Committee, [the Health, Education, Labor and Pensions Committee], across many [congressional committees]. We have been subjected to transparency, hospitals and providers and payers, for some period of time. It's hard to say that PBMs shouldn't have transparency.

    We're more focused in many respects, though, on the specialty drugs. That's where a significant portion of our spend is today. It's north of 50% and going higher. That's not the traditional role of the PBM.

    On Ozempic and Wegovy

    I love the change we're seeing in this sector of healthcare. It is such a rapidly evolving ecosystem ... and there's so much opportunity for innovation and change. I love that. But I do worry a little bit about the fact that often our science moves faster than our financial system or our economic system, and sometimes faster than our regulatory system.

    I do worry a little that these innovations catch on, particularly at a time now when people who have tried so many different therapies think, "This is it. My life will be changed." We're driving adoption at a rate faster than us knowing the effectiveness.

    We don't have a financing system in this country for that level of science. Think about Medicare. If they were allowed in Medicare, the price tag is $100 billion a year.

    I think there is promise, and I do worry. It comes back to this affordability. Because if people can't afford this medicine, or we don't fully appreciate what it takes, we're spending lots of money to keep people on these drugs. And guess what? When they go off their drugs, everything is undone.

    Related Articles
    Battle looms over proposals to expand site-neutral pay
    Key House, Senate committees advance PBM reform bills
    Prices increase at independent hospitals post-acquisition, research shows
    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    mh-20250512-doctor-pay
    Docs set for Medicare pay hike under under House GOP bill
    mh-20250512-Brett-Guthrie
    House GOP bill would make deep cuts to Medicaid
    Most Popular
    1
    Here are new state healthcare laws taking effect in 2025
    2
    Meet Modern Healthcare's 2025 Leading Women
    3
    New York-Presbyterian layoffs affect 2% of employees
    4
    Evernorth, Optum, CenterWell units buoyed insurers in Q1
    5
    Epic CEO Judy Faulkner on AI, antitrust and consolidation
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2025. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HLTH 2024
      • Sponsored Content: Vital Signs Blog
    • Opinion
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Healthcare Marketing Impact Awards
        • Innovators Awards
        • Diversity Leaders
        • Leading Women
        • Best in Business Awards
      • Conferences
        • The 2030 Playbook Conference
        • Innovations in Patient Experience
        • Leading Women Conference & Awards Luncheon
        • Leadership Summit
        • Workforce Summit
      • Galas
        • Best Places to Work Awards Gala
        • Diversity Leaders Gala
      • Virtual Briefings
        • - Looking Ahead to 2025
        • - Financial Growth
        • - Hospital of the Future
        • - Value Based Care
        • - Looking Ahead to 2026
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Skilled Nursing Facilities
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing
      • Sponsored Content